Clinical Trial Update: Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating enoximone plus extended-release metoprolol succinate in subjects with advanced chronic heart failure; the study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Enoximone (enoximone)
• Metoprolol succinate extended-release (metoprolol succinate)

Snippet

Sponsor: Gilead Sciences | Conditions: Heart Failure, Congestive | Phase 3 | Status: TERMINATED